LT-4008

N/A

Report date: 2024/11/25 10:09:24
NME

Base Information

Drug NameLT-4008
Drug Alias NameLT-4008
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAutophagy inhibitors
TargetsUpdating
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLTT Bio-Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLTT Bio-Pharma Co Ltd
Active IndicationsN/A
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A